Skip to main content
. 2020 Jun 24;71(Suppl 1):S21–S42. doi: 10.1093/cid/ciaa306

Table 2.

Summary: Nontreponemal Antibodies for Various Stages of Syphilis

Stage of Syphilis Nontreponemal Test Sensitivity Specificity Quality of Studies
Primary Serum RPR 62.5–76.1%a N/A High
Serum VDRL 62.5–78.4%b N/A High
Secondary Serum RPR 100%c N/A High
Serum VDRL 100% N/A High
Early latent Serum VDRL 85–100% N/A High
Late latent or unknown duration Serum RPR 61% N/A High (1 study)
Serum VDRL 64% N/A High (1 study)
Tertiary Serum VDRL 47–64% N/A Lower (2 studies)
Neurosyphilis CSF RPR 51.5–81.8% 81.8–100% High
CSF VDRL 49–87.5% 74–100% High
Ocular CSF VDRL 0–50% N/A Lower
Otic CSF VDRL 5.5–5.6% N/A Lower (2 studies)

For full references, see the text of the paper and Table 1.

Abbreviations: CSF, cerebrospinal fluid; RPR, rapid plasma reagin; VDRL, venereal disease research laboratory.

a1 high-quality paper reported a sensitivity of 92.7%.

b1 high-quality paper reported a sensitivity of 50%.

c1 high-quality paper reported a sensitivity of 97.2%.